NSCLC Clinical Trials Database - Free Access to 296 Studies
Access comprehensive clinical trial information for NSCLC through Pure Global AI's free database. This collection includes 296 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 102 trials are actively recruiting participants.
Research for NSCLC is being conducted in China, Japan, United States of America and 7+ other countries. Leading sponsors include AstraZeneca and Shanghai Chest Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation
A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients
A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis
Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC
An Exploratory Clinical Study of Adebelimumab in Combination With Famitinib and Chemotherapy in Patients With NSCLC
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis
Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy
The Dynamic Monitoring of Cerebrospinal Fluid ctDNA
A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer
Korean Registry of Non-Small Cell Lung Cancer Patients With EGFR Mutation
Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects
Toripalimab Therapy After Resection in High-risk Stage IA2-IB NSCLC With no Driver Alterations (EGFR or ALK)
Immuno-pet iMaging resPonses administeRed Immune checkpoiNt inhibiTor
A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer
Progression-free, disease-free, and recurrence-free survivals as surrogate in NSCLC perioperative chemotherapy trials
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Safety and Efficacy of NK510 to Treat NSCLC
Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens
Pure Global AI provides free access to 296 clinical trials studying NSCLC, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Shanghai Chest Hospital, Novartis Pharma Services Inc., among others.